Lakefront Biotherapeutics NV (LKFT) — Defensive Interval Ratio
Lakefront Biotherapeutics NV (LKFT) has a Defensive Interval Ratio of 10793 days as of March 2026. Defensive assets of $2.97 Billion (cash $-, short-term investments $2.92 Billion, receivables $54.03 Million) cover 10793 days of daily cash needs of $275.13K/day. For the complete balance sheet picture, see Lakefront Biotherapeutics NV (LKFT) total assets.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Lakefront Biotherapeutics NV Defensive Interval Ratio (2022–2025)
This chart shows how Lakefront Biotherapeutics NV's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 10793 days, meaning defensive assets of $2.97 Billion can fund 10793 days of operations without new revenue. Check how resilient are Lakefront Biotherapeutics NV's assets to evaluate the company's liquid asset resilience ratio.
Annual Defensive Interval Ratio for Lakefront Biotherapeutics NV (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Lakefront Biotherapeutics NV from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 7076 days | $2.96 Billion | $418.80K/day | $- | $2.91 Billion | ▲ +3715 days |
| 2024 | 3361 days | $3.09 Billion | $918.03K/day | $- | $3.05 Billion | ▲ +348 days |
| 2023 | 3013 days | $3.54 Billion | $1.17 Million/day | $- | $3.52 Billion | ▲ +489 days |
| 2022 | 2525 days | $3.61 Billion | $1.43 Million/day | $- | $3.59 Billion | — |